https://orcid.org/0000-0002-7714-2256
References
- MenonMP, EvbuomwanMO, RosaiJ, JaffeES, PittalugaS. A subset of Rosai-Dorfman disease cases show increased IgG4-positive plasma cells: another red herring or a true association with IgG4-related disease?Histopathol.64(3), 455–459 (2013).
- WHO Classification of Tumours Editorial Board. WHO classification of tumours. 5th Edition. Classification of haematolymphoid tumors.International Agency for Research on Cancer, Lyon (2022).
- DoglioniC. Rosai-Dorfman disease. A legacy of Professor Rosai that is still not exploited completely. Pathologica.113(5), 388–395 (2021).
- SymmsNP, CugatiG, VasudevanMC, RamamurthiR, PandeA. Intracranial Rosai Dorfman disease: report of three cases and literature review. Asian J. Neurosurg.5(2), 19–30 (2010).
- FraterJL, MaddoxJS, ObadiahJM, HurleyM. Cutaneous Rosai-Dorfman disease: comprehensive review of cases reported in the medical literature since 1990 and presentation of an illustrative case. J. Cutan. Med. Surg.10(6), 281–290 (2006).
- DaliaS, SagatysE, SokolL, KubalT. Rosai-Dorfman Disease: tumor biology clinical features, pathology, and treatment. Cancer Control.21(4), 322–327 (2014).
- ThomasKD, DelahoussayeP, SchwartzMR, AyalaAG, RoJY. Extranodal Rosai-Dorfman disease involving soft tissue associated with increased IgG4 plasma cells. Hum. Pathol.24, 200488 (2021).
- MantillaJG, Goldberg-SteinS, WangY. Extranodal Rosai-Dorfman Disease: clinicopathologic series of 10 patients with radiologic correlation and review of the literature. Am. J. Clin. Pathol.145(2), 211–221 (2016).